Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Liam Ratcliffe currently holds 17,096 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Liam Ratcliffe has been a net seller of DCPH stock. They have purchased $68.4M and sold $71.6M worth of shares.
Liam Ratcliffe's most recent insider trade was on Jun 9, 2026, when they sold 17,096 shares at $0.00 per share.
Liam Ratcliffe serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 86 insider transactions totaling $140.0M over their tenure at the company.
Liam Ratcliffe holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Liam Ratcliffe has shown a selling trading pattern, with $68.4M in total purchases and $71.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Liam Ratcliffe was on Dec 18, 2020, when they purchased $10.0M worth of ARVN shares. This transaction involved 142,857 shares at $70.00 per share.
Liam Ratcliffe currently owns 17,096 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Liam Ratcliffe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Liam Ratcliffe has 86 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Liam Ratcliffe and 40,000+ other insiders.